NASDAQ:ABEO - Abeona Therapeutics News Headlines Sign in or create an account to add this stock to your watchlist. Get Started $7.44 -0.01 (-0.13 %) (As of 05/19/2019 04:00 PM ET)Previous Close$7.44Today's Range$7.30 - $7.5952-Week Range$6.26 - $21.45Volume622,657 shsAverage Volume355,740 shsMarket Capitalization$365.75 millionP/E RatioN/ADividend YieldN/ABeta1.92 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Headlines Abeona Therapeutics (NASDAQ ABEO) News Headlines Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance DateHeadlineJefferies Financial Group Equities Analysts Cut Earnings Estimates for Abeona Therapeutics Inc (ABEO)www.americanbankingnews.com - May 19 at 3:08 AMResearch Analysts Offer Predictions for Abeona Therapeutics Inc's FY2023 Earnings (ABEO)www.americanbankingnews.com - May 17 at 7:39 AMResearch Analysts Offer Predictions for Abeona Therapeutics Inc's Q2 2019 Earnings (ABEO)www.americanbankingnews.com - May 17 at 6:43 AMEdited Transcript of ABEO earnings conference call or presentation 14-May-19 2:00pm GMTfinance.yahoo.com - May 15 at 11:29 AMAbeona Therapeutics Inc (ABEO) Q1 2019 Earnings Call Transcriptwww.fool.com - May 14 at 10:01 PMAbeona Therapeutics (ABEO) Earns Buy Rating from Cantor Fitzgeraldwww.americanbankingnews.com - May 14 at 2:36 PMAbeona Therapeutics Treats First Patient in Second Cohort of Phase 1/2 Clinical Trial for ABO-101 in Sanfilippo Syndrome Type B (MPS IIIB)finance.yahoo.com - May 14 at 11:43 AMAbeona Therapeutics Inc.: Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlightswww.finanznachrichten.de - May 11 at 11:27 AMAbeona Therapeutics misses by $0.09seekingalpha.com - May 11 at 11:27 AMAbeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlightswww.globenewswire.com - May 11 at 11:27 AMAbeona Therapeutics Inc.: Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual Meetingwww.finanznachrichten.de - May 8 at 11:25 AMAbeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual Meetingfinance.yahoo.com - May 8 at 11:25 AMAbeona Therapeutics Announces Participation in Upcoming Investor Conferencesfinance.yahoo.com - May 7 at 4:29 PMAbeona Therapeutics Inc (ABEO) Receives Average Recommendation of "Buy" from Brokerageswww.americanbankingnews.com - May 6 at 12:37 PMAbeona Therapeutics' (ABEO) Buy Rating Reaffirmed at HC Wainwrightwww.americanbankingnews.com - May 6 at 10:32 AMAbeona Therapeutics Inc (ABEO) Expected to Announce Quarterly Sales of $1.21 Millionwww.americanbankingnews.com - May 5 at 8:50 PM-$0.31 Earnings Per Share Expected for Abeona Therapeutics Inc (ABEO) This Quarterwww.americanbankingnews.com - May 3 at 10:23 PMEarnings Preview: Abeona Therapeutics (ABEO) Q1 Earnings Expected to Declinefinance.yahoo.com - May 3 at 4:23 PMAbeona Therapeutics (ABEO) Given Buy Rating at Maxim Groupwww.americanbankingnews.com - May 1 at 4:14 PMAbeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM™ Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meetingfinance.yahoo.com - May 1 at 11:05 AMAbeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 for Treatment of Cystic Fibrosis at American Society of Gene and Cell Therapy Annual Meetingfinance.yahoo.com - April 30 at 11:05 AMIs Abeona Therapeutics's (NASDAQ:ABEO) 173% Share Price Increase Well Justified?finance.yahoo.com - April 16 at 1:05 PMNew IND-enabling data for ABO-202 in CLN1 disease also to be highlightedwww.globenewswire.com - April 15 at 4:26 PMAbeona Therapeutics to Present Data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual Meetingfinance.yahoo.com - April 15 at 4:26 PMAbeona Therapeutics Inc.: Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)www.finanznachrichten.de - April 4 at 10:12 AMAbeona's ABO-101 Fast Track'd for MPS IIIB; shares up 5% premarketseekingalpha.com - April 4 at 10:12 AMAbeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)finance.yahoo.com - April 4 at 10:12 AMEdited Transcript of ABEO earnings conference call or presentation 19-Mar-19 2:00pm GMTfinance.yahoo.com - March 20 at 11:22 AMAbeona Therapeutics Inc. (ABEO) CEO João Siffert on Q4 2018 Results - Earnings Call Transcriptseekingalpha.com - March 19 at 4:18 PMAbeona Therapeutics Inc.: Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Resultswww.finanznachrichten.de - March 19 at 12:13 PMAbeona Therapeutics Inc. (ABEO) After Hours Tradingwww.nasdaq.com - March 19 at 12:13 PMAbeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Resultsfinance.yahoo.com - March 19 at 12:13 PMAbeona Therapeutics: 4Q Earnings Snapshotfinance.yahoo.com - March 19 at 12:13 PMAbeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference - GlobeNewswireglobenewswire.com - February 22 at 4:00 PMAbeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conferencefinance.yahoo.com - February 22 at 12:56 PMWhat Investors Should Know About Abeona Therapeutics Inc.’s (NASDAQ:ABEO) Financial Strengthfinance.yahoo.com - February 22 at 12:56 PMAbeona Therapeutics (ABEO) Joao Siffert MD as New Chief Executive Officer - StreetInsider.comwww.streetinsider.com - February 11 at 4:13 PMAbeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officer - GlobeNewswireglobenewswire.com - February 11 at 4:13 PMAbeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officerfinance.yahoo.com - February 11 at 4:13 PMSangamo selloff weighs on gene therapy developers - Seeking Alphaseekingalpha.com - February 8 at 11:23 AMAbeona up 13% ahead of gene therapy presentationsseekingalpha.com - February 4 at 4:09 PMAbeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™finance.yahoo.com - January 31 at 11:00 AMNew finance chief at Abeonaseekingalpha.com - January 8 at 4:26 PMAbeona Therapeutics Strengthens Financial Leadership with New Executive Appointmentsfinance.yahoo.com - January 8 at 4:26 PMHow Should Investors Feel About Abeona Therapeutics Inc.’s (NASDAQ:ABEO) CEO Pay?finance.yahoo.com - December 25 at 10:10 AMIs Abeona Therapeutics Inc (ABEO) A Good Stock To Buy?finance.yahoo.com - December 13 at 8:14 AMAbeona Therapeutics (ABEO) in Focus: Stock Moves 5.5% Higherfinance.yahoo.com - December 11 at 10:56 AMAbeona to launch pivotal study of EB-101 in RDEB in mid-2019, new CF program launched; shares up 6%seekingalpha.com - December 6 at 4:10 PMAbeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Next Generation AIM™ Vector Platform at 2018 R&D Dayfinance.yahoo.com - December 6 at 4:10 PMMoving Average Crossover Alert: Abeona Therapeuticsfinance.yahoo.com - December 3 at 10:26 AM This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: What are the benefits of a balanced fund? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.